Bragar Eagel & Squire, P.C. Is Investigating Quanterix and TransMedics and Encourages Investors to Contact the FirmNEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Quanterix Corporation (
NASDAQQTRX) and TransMedics Group, Inc.
NASDAQ:TMDXNASDAQTMDX)
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates LGTY, AZPN, RDW, QTRX on Behalf of ShareholdersNEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CCRN, NARI, VTS, QTRX on Behalf of ShareholdersNEW YORK, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NARI, QTRX, CTV on Behalf of ShareholdersNEW YORK, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Quanterix Provides Update on Financial Performance
Quanterix Corporation (
NASDAQQTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced selected preliminary, unaudited results for the fourth quarter and full year ended December 31, 2024.
QTRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Quanterix Corporation Is Fair to Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Quanterix Corporation (
NASDAQQTRX) and Akoya Biosciences, Inc. is fair to Quanterix shareholders. Upon completion of the proposed transaction, Quanterix shareholders will own approximately 70% of the combined company.
David R. Walt Receives National Medal of Technology and Innovation
Quanterix Corporation (
NASDAQQTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that David R. Walt, co-inventor of the Company’s Simoa technology has received the National Medal of Technology and Innovation, bestowed by the President of the United States.
Quanterix to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Quanterix Corporation (
NASDAQQTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that President and Chief Executive Officer Masoud Toloue will present at the 43rd Annual J.P. Morgan Healthcare Conference taking place January 13th-16th at the Westin St. Francis Hotel in San Francisco, CA. Quanterix’s presentation will be on Wednesday, January 15, 2025, at 4:30 p.m., PST. In addition to the session, Quanterix will also host one-on-one meetings with institutional investors during the conference.
Quanterix Expands Capabilities with Strategic Acquisition of EMISSION
Quanterix Corporation (
NASDAQQTRX), a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, today announced the acquisition of EMISSION iNC. (“EMISSION”). Quanterix expects the transaction will close in January 2025.
The Schall Law Firm Invites Shareholder Contributions To An Inquiry Into Quanterix Corporation's Possible Securities FraudLOS ANGELES, CA / ACCESSWIRE / December 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Quanterix Corporation ("Quanterix" or "the Company") (
NASDAQQTRX) for violations of the securities laws.
Quanterix Corporation Is Being Investigated For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law FirmLOS ANGELES, CA / ACCESSWIRE / December 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Quanterix Corporation ("Quanterix" or "the Company") (
NASDAQQTRX) for violations of the securities laws.
The Schall Law Firm Invites Shareholder Contributions To An Inquiry Into Quanterix Corporation For Possible Securities FraudLOS ANGELES, CA / ACCESSWIRE / December 14, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Quanterix Corporation ("Quanterix" or "the Company") (
NASDAQQTRX) for violations of the securities laws.
Quanterix Corporation Is Being Investigated For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law FirmLOS ANGELES, CA / ACCESSWIRE / December 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Quanterix Corporation ("Quanterix" or "the Company") (
NASDAQQTRX) for violations of the securities laws.
The Schall Law Firm Invites Stockholder Participation In An Inquiry Into Quanterix Corporation For Possible Securities FraudLOS ANGELES, CA / ACCESSWIRE / December 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Quanterix Corporation ("Quanterix" or "the Company") (
NASDAQQTRX) for violations of the securities laws.
QUANTERIX ALERT: Bragar Eagel & Squire, P.C. is Investigating Quanterix Corporation on Behalf of Quanterix Stockholders and Encourages Investors to Contact the FirmNEW YORK, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Quanterix Corporation (“Quanterix” or the “Company”) (
NASDAQQTRX) on behalf of Quanterix stockholders. Our investigation concerns whether Quanterix has violated the federal securities laws and/or engaged in other unlawful business practices.
